Vascular damage

Vascular damage induced by ions and cytotoxic drugs are frequent events and known as chemical phlebitis. Swissmedendi’s infusion technology device HC100© assist in the prevention of
• Loss of endothelial cells
• Inflammatory cells infiltration
• Edema
• Thrombosis
• Sclerosis
Injuries can be proximal or distal to the catheter tips and usually irritates the venousendothelial cells over a longer distance from the catheter tip.

Unique Methods and Technology

Swissmedendi owns unique technology able to protect patients’ veins from vesicant agents causing irreversible endothelial damage; saving lives and reducing risks and injuries to patients and offering enormous cost saving.

Devices

All our devices are disposable non invasive class IIa (Europe) and class 2 (USA). These do not vary therapeutics administration protocols, infusion speed or drug concentration.

Employing the technology will help hospitals to manage costs, enable doctors to focus more on their patients’ needs, and improve patients’ quality of life.

The devices are easy to use and adaptable to devices currently in use.

Intellectual Property

Patents Granted.
CE certified #1715/MDD IMQ 01/10/2014.